Share
18 Posts.
lightbulb Created with Sketch. 9
clock Created with Sketch.
04/08/21
10:56
Share
Originally posted by eason2946:
↑
So why even bother doing it then? If all the commercial deals that RAP has signed so far has "no material on its operating results"? Shouldn't RAP know this already during the commercial negotiation? To date, RAP management hasn't been able to explain how much revenue each deal is going to generate, how much is RAP charging for the license and what's the expected usage/number. These are simple questions that SHs deserves to know. How else are you going to value a company that's supposedly in 'revenue phase'? It's good to be able to say they're signing up new customers, but then the quarterly results/annual reports says otherwise. I thought Medgate might be the turning point for RAP. Unfortunately turns out it's the same story over and over again and I really feel for the SHs who's been suffering. GLTAH and DYOR
Expand
Easy to explain @eason2946 , RAP have no baseline to provide those forecasts. It would be irresponsible for them to do so and would have a detrimental effect on the SP if they provided a wildly inaccurate forecast.